Skip to main content
Clinical Trials/ISRCTN17755571
ISRCTN17755571
Completed
未知

A randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) for depressed non-responders to Increasing Access to Psychological Therapies (IAPT) high intensity therapies

Sussex Partnership NHS Foundation Trust0 sites259 target enrollmentMarch 2, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Depression
Sponsor
Sussex Partnership NHS Foundation Trust
Enrollment
259
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36658663/ (added 23/01/2023)

Registry
who.int
Start Date
March 2, 2021
End Date
October 23, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 04/01/2022:
  • 1\. Non\-response to a minimal effective dose of high\-intensity treatment in IAPT (at least 12 sessions, in line with NICE draft guideline suggestions) defined in line with the caseness threshold adopted by IAPT as a Patient Health Questionnaire\-9 (PHQ\-9\) score of 10 or higher
  • 2\. Meeting criteria for a current episode of Major Depression according to DSM\-5 as assessed through the Mini International Neuropsychiatric Interview for DSM\-5 (MINI)
  • 3\. Aged 18 years or older
  • 4\. Access to a working internet connection to participate in video conferencing assessments and interventions. According to the IAPT database, the majority of patients who receive high\-intensity psychological treatment will also have received treatment with antidepressant medication, and most of these patients will therefore meet consensus criteria for treatment resistance
  • Previous inclusion criteria:
  • 1\. Non\-response to a minimal effective dose of high\-intensity treatment in IAPT (at least 12 sessions, in line with NICE draft guideline suggestions) defined in line with the caseness threshold adopted by IAPT as a Patient Health Questionnaire\-9 (PHQ\-9\) score of 10 or higher
  • 2\. Meeting criteria for a current episode of Major Depression according to DSM\-5 as assessed through the Mini International Neuropsychiatric Interview for DSM\-5 (MINI)
  • 3\. Age between 18 and 65 years
  • 4\. Access to a working internet connection to participate in video conferencing assessments and interventions. According to the IAPT database, the majority of patients who receive high\-intensity psychological treatment will also have received treatment with antidepressant medication, and most of these patients will therefore meet consensus criteria for treatment resistance

Exclusion Criteria

  • Current exclusion criteria as of 04/01/2022:
  • 1\. Based on the judgment of their IAPT therapist they are eligible for secondary care specialist services
  • 2\. Receiving individual psychotherapy or counselling from other sources than the NHS at a frequency of more than once a month
  • 3\. They present with a level of risk to self or others that cannot be safely managed in a primary care service context (i.e. active suicidal plans), a history of psychosis or psychotic symptoms, a current episode of mania, alcohol or substance abuse or dependence within the past 3 months, current post\-traumatic stress disorder, obsessive\-compulsive disorder or eating disorder
  • 4\. They suffer from any other significant disease or disorder that may either put the participant at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial
  • 5\. Have an insufficient ability to understand or read English
  • 6\. Patients who are currently taking antidepressant medication will be allowed into the trial and medication use will be documented for statistical analysis
  • Previous exclusion criteria:
  • 1\. Based on the judgment of their IAPT therapist they are eligible for secondary care specialist services
  • 2\. Receiving individual psychotherapy or counselling from other sources than the NHS at a frequency ofmore than once a month

Outcomes

Primary Outcomes

Not specified

Similar Trials